Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health issues. The high relapse rates following initial treatments make the search for novel immunotherapies urgent. However, the effectiveness of these therapies often depends on a functional immune microenvironment in MM patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup